Zimmer
This article was originally published in The Gray Sheet
Executive Summary
Bristol-Myers Squibb orthopedics spin-off commences independent public trading Aug. 7 on the New York Stock Exchange under the symbol "ZMH" (1"The Gray Sheet" July 30, 2001, p. 10)
You may also be interested in...
Merit Margin Growth, Cath-Lab Strength Aid Stock's Momentum In August
Merit Medical stock continued to build momentum in August following the July release of strong second quarter financial results that reflect both improving business fundamentals like gross margins and competitive strength in its core cath-lab accessory market.
Merit Margin Growth, Cath-Lab Strength Aid Stock's Momentum In August
Merit Medical stock continued to build momentum in August following the July release of strong second quarter financial results that reflect both improving business fundamentals like gross margins and competitive strength in its core cath-lab accessory market.
Zimmer's NexGen Knees Help Lift Second-Quarter Revenues 13% To $294 Mil.
A 28% jump in U.S. sales of knee implants and a 26% increase in domestic artificial hip revenues helped propel Zimmer Holdings's second-quarter corporate revenues ahead 13% to $294.3 mil., the firm reported July 25.